{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:01:01Z","timestamp":1778234461270,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["# 5R01DA045055-02"],"award-info":[{"award-number":["# 5R01DA045055-02"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004459","name":"RAND Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In response to the opioid crisis, U.S. states have passed laws requiring urine drug testing (UDT) when opioid analgesics are prescribed for chronic pain. We sought to identify state law UDT requirements.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We searched NexisUni legal database using terms related to UDT, chronic pain, and opioids. We included laws effective during spring 2022 that required UDT when opioids were prescribed for chronic pain. We performed deductive content analysis, coding laws for mandated UDT frequency, type of clinician and type of payer to whom the law applied, and circumstances under which UDT was mandated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found 32 laws across 13 states that met our inclusion criteria. UDT requirements varied substantially by state, including with regard to the type of clinician to whom the law applied, the mandated frequency of UDT (eg, at initiation\/assessment, at least annually, more than once per year), and the circumstances in which UDT was mandated (eg, patient had substance use disorder; dosage\/day threshold).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Relatively few states have UDT mandates associated with prescribing opioids as chronic pain treatment. When developing policy indicators for empirical studies, researchers evaluating how UDT policy affects health outcomes must consider the complexity and lack of uniformity of UDT requirements. In addition, even if states mandate UDT, it is unclear whether clinicians understand the best way to use the test results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnad103","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:48:49Z","timestamp":1691498929000},"page":"1306-1317","source":"Crossref","is-referenced-by-count":2,"title":["Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6369","authenticated-orcid":false,"given":"Barbara","family":"Andraka-Christou","sequence":"first","affiliation":[{"name":"School of Global Health Management & Informatics, University of Central Florida , Orlando, FL 32801, United States"},{"name":"Department of Internal Medicine (Secondary Joint Appointment), University of Central Florida , Orlando, FL 32827, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"McAvoy","sequence":"additional","affiliation":[{"name":"O'Neill School of Public and Environmental Affairs, Indiana University , Bloomington, IN 47405, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam J","family":"Gordon","sequence":"additional","affiliation":[{"name":"Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System , Salt Lake City, UT 84108, United States"},{"name":"Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine , Salt Lake City, UT 84108, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Ohama","sequence":"additional","affiliation":[{"name":"The Cardiac and Vascular Institute , Gainesville, FL 32605, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Brach","sequence":"additional","affiliation":[{"name":"Trinity College , Hartford, CT 06106, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin A","family":"Taylor","sequence":"additional","affiliation":[{"name":"RAND Corporation , Santa Monica, CA 90401, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Vaiana","sequence":"additional","affiliation":[{"name":"RAND Corporation , Santa Monica, CA 90401, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Saloner","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University , Baltimore, MD 21205, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley D","family":"Stein","sequence":"additional","affiliation":[{"name":"RAND Corporation , Pittsburgh, PA 15238, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"2023120111261890900_pnad103-B1","author":"Ahmad"},{"issue":"1","key":"2023120111261890900_pnad103-B2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/add.14394","article-title":"A crisis of opioids and the limits of prescription control: United States","volume":"114","author":"Kertesz","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"2023120111261890900_pnad103-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"24","key":"2023120111261890900_pnad103-B4","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"2023120111261890900_pnad103-B5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/pm\/pnac124","article-title":"Systematic identification and categorization of opioid prescribing\/dispensing policies in 16 states and Washington D.C","volume":"24","author":"Andraka-Christou","year":"2023","journal-title":"Pain Med"},{"issue":"4","key":"2023120111261890900_pnad103-B6","first-page":"38","article-title":"A practical guide to urine drug monitoring","volume":"35","author":"Raouf","year":"2018","journal-title":"Fed Pract."},{"issue":"2","key":"2023120111261890900_pnad103-B7","doi-asserted-by":"crossref","first-page":"e2036687","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023120111261890900_pnad103-B8","doi-asserted-by":"crossref","first-page":"108137","DOI":"10.1016\/j.drugalcdep.2020.108137","article-title":"The state of the science in opioid policy research","volume":"214","author":"Schuler","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"2023120111261890900_pnad103-B9","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1377\/hlthaff.2018.0512","article-title":"Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions","volume":"37","author":"Bao","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"2023120111261890900_pnad103-B10","author":"Dedoose","year":"2018"},{"key":"2023120111261890900_pnad103-B11","author":"U.S. Drug Enforcement Administration"},{"key":"2023120111261890900_pnad103-B12","year":"2016"},{"key":"2023120111261890900_pnad103-B13","year":"2020"},{"key":"2023120111261890900_pnad103-B14","year":"2020"},{"key":"2023120111261890900_pnad103-B15","year":"2020"},{"key":"2023120111261890900_pnad103-B16","year":"2020"},{"key":"2023120111261890900_pnad103-B17","year":"2020"},{"key":"2023120111261890900_pnad103-B18","year":"2018"},{"key":"2023120111261890900_pnad103-B19","year":"2018"},{"key":"2023120111261890900_pnad103-B20","year":"2022"},{"key":"2023120111261890900_pnad103-B21","year":"2019"},{"key":"2023120111261890900_pnad103-B22","year":"2020"},{"key":"2023120111261890900_pnad103-B23","year":"2020"},{"key":"2023120111261890900_pnad103-B24","author":"Davis","year":"2017"},{"issue":"7","key":"2023120111261890900_pnad103-B25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/02692163211015567","article-title":"Assessment tools for problematic opioid use in palliative care: a scoping review","volume":"35","author":"Lau","year":"2021","journal-title":"Palliat Med"},{"issue":"14","key":"2023120111261890900_pnad103-B26","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1200\/JCO.22.01413","article-title":"Racial and ethnic disparities in opioid access and urine drug screening among older patients with poor-prognosis cancer near the end of life","volume":"41","author":"Enzinger","year":"2023","journal-title":"J Clin Oncol"},{"issue":"3","key":"2023120111261890900_pnad103-B27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1370\/afm.1242","article-title":"Racial differences in primary care opioid risk reduction strategies","volume":"9","author":"Becker","year":"2011","journal-title":"Ann Fam Med"},{"issue":"1","key":"2023120111261890900_pnad103-B28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08897077.2015.1110742","article-title":"Predictors of urine drug testing for patients with chronic pain: results from a national cohort of U.S. veterans","volume":"37","author":"Morasco","year":"2016","journal-title":"Subst Abus"},{"issue":"1","key":"2023120111261890900_pnad103-B29","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1080\/08897077.2022.2095082","article-title":"Patient-centered quality measurement for opioid use disorder: development of a taxonomy to address gaps in research and practice","volume":"43","author":"Kelley","year":"2022","journal-title":"Subst Abus"},{"issue":"6","key":"2023120111261890900_pnad103-B30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5055\/jom.2007.0022","article-title":"Family physicians' proficiency in urine drug test interpretation","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag"},{"issue":"2","key":"2023120111261890900_pnad103-B31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5055\/jom.2007.0044","article-title":"Urine drug test interpretation: What do physicians know?","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag"},{"issue":"1","key":"2023120111261890900_pnad103-B32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/pm\/pnx285","article-title":"Rational urine drug monitoring in patients receiving opioids for chronic pain: consensus recommendations","volume":"19","author":"Argoff","year":"2018","journal-title":"Pain Med"},{"issue":"4","key":"2023120111261890900_pnad103-B33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.5055\/jom.2022.0723","article-title":"Definitive urine drug test findings in patients prescribed opioids for pain from a large national database","volume":"18","author":"Guevara","year":"2022","journal-title":"J Opioid Manag"},{"key":"2023120111261890900_pnad103-B34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today's fentanyl crisis: Prohibition's Iron Law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"6","key":"2023120111261890900_pnad103-B35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/ADM.0000000000000258","article-title":"Definitive LC-MS\/MS drug monitoring impacts substance-use treatment planning and patient outcomes: a brief report","volume":"10","author":"Rzetelny","year":"2016","journal-title":"J Addict Med"},{"key":"2023120111261890900_pnad103-B36","year":"2021"},{"key":"2023120111261890900_pnad103-B37","author":"Centers for Medicare & Medicaid Services","year":"2023"},{"issue":"7","key":"2023120111261890900_pnad103-B38","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamainternmed.2020.0989","article-title":"Trends in utilization of prescribed controlled substances in US commercially insured adults, 2004-2019","volume":"180","author":"Bykov","year":"2020","journal-title":"JAMA Intern Med"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnad103\/51268004\/pnad103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/24\/12\/1306\/53940636\/pnad103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/24\/12\/1306\/53940636\/pnad103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T11:26:48Z","timestamp":1701430008000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/24\/12\/1306\/7238787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,8,8]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnad103","relation":{},"ISSN":["1526-4637"],"issn-type":[{"value":"1526-4637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12,1]]},"published":{"date-parts":[[2023,8,8]]}}}